Amicus Therapeutics
FOLD
#3322
Rank
A$6.66 B
Marketcap
A$21.54
Share price
0.42%
Change (1 day)
44.78%
Change (1 year)

Market capitalization of Amicus Therapeutics (FOLD)

Market cap: A$6.66 Billion

As of January 2026 Amicus Therapeutics has a market cap of A$6.66 Billion. This makes Amicus Therapeutics the world's 3322th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amicus Therapeutics from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$6.66 B1.22%
2025A$6.58 B42.24%
2024A$4.62 B-24.26%
2023A$6.10 B21.16%
2022A$5.04 B13.56%
2021A$4.43 B-43.27%
2020A$7.82 B120.22%
2019A$3.55 B37.97%
2018A$2.57 B-15.97%
2017A$3.06 B212.3%
2016A$0.98 B-41.05%
2015A$1.66 B71.37%
2014A$0.97 B494.96%
2013A$0.16 B27.57%
2012A$0.12 B10.09%
2011A$0.11 B-27.19%
2010A$0.15 B59.36%
2009A$0.10 B-60.16%
2008A$0.25 B-8.01%
2007A$0.27 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Amicus Therapeutics was reported to be:

A$6.64 Billion
by Nasdaq info icon info icon
A$6.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
A$37.19 B 458.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$16.13 B 142.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.14 B-82.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$153.72 B 2,207.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A$0.67 B-89.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$392.01 B 5,785.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark